Clostridium difficile infection is a serious condition responsible for significant morbidity and
mortality, especially in patients being treated with antimicrobials. Increasing frequency of the …

Clostridium difficile infection (CDI) is increasingly prevalent, dangerous and challenging to
prevent and manage. Despite intense national and international attention the incidence of …

Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium. The clinical
features of C. difficile infections (CDIs) can vary, ranging from the asymptomatic carriage and …

Clostridioides difficile is the most prevalent pathogen of nosocomial diarrhea. In the United
States, over 450,000 cases of C. difficile infection (CDI), responsible for more than 29,000 …

Clostridium difficile is a leading cause of antibiotic-associated diarrhea worldwide. The
diagnosis of C. difficile infection (CDI) requires both clinical manifestations and a positive …

Since the discovery of Clostridium difficile infection (CDI) in the 1970s, there has been an
increase in the incidence, severity, and recurrence rate of the disease. We reviewed the …

Introduction: Clostridium difficile infection (CDI) has become a significant healthcare-
associated infection and is strongly associated with antibiotic use. Practice guidelines have …

Clostridium difficile infection, also known as C. difficile‐associated diarrhea (CDAD), is the
most common cause of nosocomial diarrhea, typically initiated by the use of broad‐spectrum …

Clostridium difficile infection (CDI) is the primary cause of antibiotic-associated diarrhea, and
is a significant nosocomial disease. In the past ten years, variant toxin-producing strains of …

Clostridioides difficile is a Gram-positive, spore-forming, toxin-producing anaerobe, and an
important nosocomial pathogen. Due to the strictly anaerobic nature of the vegetative form …